Adjunctive dexamethasone in adults with meningococcal meningitis

Abstract

This study provides Class III evidence that adjuvant dexamethasone in adults with meningococcal meningitis does not increase negative outcomes such as deafness, death, or negative Glasgow Outcome Scale measures.